Paolo Vineis University of Torino and ISI Foundation EPIC: Molecular markers of carcinogenesis in a large prospective study.

Slides:



Advertisements
Similar presentations
High Resolution studies
Advertisements

GLOBAL PROBLEM. PRESENTED BY DR.RAMESH KUMAR SAHARIA (Consultant Onco- Surgeon) Sridhar Cancer care Center Srimanta Sankerdev Hospital and Research Institute.
TOBACCO Americas #1 Killer. The Smoking Roller Coaster nicotine goes into the bloodstream, the bodys defenses swing into action, heart beat increases,
Epidemiologic Study Designs Clinical Studies & Objective Medicine
ISI Foundation G. Matullo, P. Vineis M. Manuguerra, F. Saletta DNA repair genes and cancer Web registry on DNA repair polymorphisms and cancer risk website.
SEARCH School Environment And Respiratory health of CHildren an international research project within the Indoor Air Quality in European Schools. Preventing.
Participation rates in telephone administered 24-h-recalls Experience from the Norwegian EPIC cohort.
Plant Sterols – a product case study
Paolo Vineis Imperial College London Causal models of carcinogenesis: a historical perspective.
This grey area will not appear in your presentation. Tobacco and Cancer Still a problem in today’s youth! Presentation prepared by: Canadian Cancer Society,
SMOKING TRUE OR FALSE Go to the RIGHT side of the room if statement is TRUE Go to the LEFT side of the room if the statement is FALSE.
How to optimize the study design 1. Theory and biological plausibility Paolo Vineis Firenze 19 June 2013.
External validity: to what populations do our study results apply?
ECNIS Web-based course in Molecular Epidemiology in Cancer Biomarker Validation Slide B1.1.
B.Sc, MSc, MD. WINDSOR UNIVERITY Samuel Taiwo Alawode.
Cohort Studies.
PATHOPHYSIOLOGY of TOBACCO-RELATED DISEASE SURGEON GENERAL’s REPORT: THE HEALTH CONSEQUENCES of SMOKING Cancer Cardiovascular disease Respiratory.
GENE-ENVIRONMENT INTERACTION Herman Autrup Dept Environmental Medicine Institute of Public Health University of Aarhus.
UNIVERSITY OF CAMBRIDGE
Tobacco Lesson 1. Tobacco has ____________ effects on almost all body systems. cigarette lungs cancer tobacco harmful crave oxygen.
Stepwise model to study folate and pancreatic cancer in the international study setting - Results from the European Prospective Investigation into Cancer.
Cross-sectional study. Definition in Dictionary of pharmaceutical medicine 2009 by G Nahler Dictionary of pharmaceutical medicine cross-sectional study.
1 ETS exposure of children  Respiratory diseases wheezing diminished pulmonary functions asthma bronchiale chronic bronchitis pneumonia  middle ear infections.
What are lifestyle diseases?
What type of study is this?
More Genetics.
Design Elements: Primitives. Try to Make these Primitives.
Epigenetics of Celiac Disease MEDICEL Malta 2011.
Chia-Fang Wu 1 Ming-Tsang Wu 1-2 Inn-Wen Chong 3 Kuen-Yuh Wu 4 Chi-Kung Ho 1 Chien-Hung Lee 5 Jhi-Jhu Huang 3 Chia-Tsuan Huang 2 Chung-Ying Lee 2 Trong-Neng.
 Most frequently diagnosed cancer worldwide › About 1.35 million new cases diagnosed worldwide each year  Leading cause of cancer deaths in the United.
Cancer Epidemiology An Introduction The Epidemiologic Perspective Aims of Cancer Epidemiology Methods of Epidemiology Historical Perspective and Examples.
Cancer Biology Ms. Sneha Singh Department of Zoology, DAVCG, Yamunanagar.
BIOLOGIC MARKERS IN OCCUPATIONAL AND ENVIRONMENTAL MEDICINE By: Dr Chavoshi.
Prospective Study Cohort Study Assis.Prof.Dr Diaa Marzouk Community Medicine.
Zuo-Feng Zhang, MD, PhD Epi242, Prospective:  Cohort Studies: Observational studies  Intervention Studies, Clinical Trials  Nested Case-Control.
How to optimize the study design -
Smoking Tobacco Chapter 13. History of Tobacco ► Tobacco - Nicotiana Tabacum and Nicotiana Rustica ► Smoking practiced among the early Mayas, probably.
ANALYTICAL STUDIES Prospective Studies COHORT Prepared by: Dr. Sahar Sabbour Community Medicine Department.
Environmental Carcinogenesis White Coat Wonders Lisa Lam Zara Khan.
Page 1 Author: Bokor Emőke – Anita (University of Medicine and Pharmacy Tîrgu-Mure, General Medicine, 6 th year) Supervisor: Dr. Germán - Salló Márta,
Long-term exposure to air pollution and asthma hospitalisations in older adults: a cohort study Zorana Jovanovic Andersen ERS Conflict of interest.
Environmental Tobacco Smoke (ETS) and the Risk of Head and Neck Cancer: INHANCE Consortium Yuan-Chin Amy Lee Gene-Environmental Epidemiology Group International.
Effects of Smoking on Health Prepared by Amr Said Dahroug.
Dr Heather O Dickinson Department of Child Health University of Newcastle
Tobacco: The Smoker’s Gun A tool for trainers Ministry of Health and Quality of Life, Mauritius (Health Information, Education and Communication Unit)
Paolo Vineis University of Torino and ISI Foundation, Torino, Italy address: GENE-ENVIRONMENT INTERACTIONS IN CANCER.
An Introductory Lecture to Environmental Epidemiology Part 4. Some Issues in Exposure Assessment Mark S. Goldberg INRS-Institut Armand-Frappier, University.
By Ed and Bella..x. Equation for Respiration  Glucose + oxygen --> carbon dioxide + water + energy  C 6 H 12 O 6 + 6O 2 --> 6CO 2 + 6H 2 O + energy.
EPIDEMIOLOGY AND AETIOLOGY OF LUNG CANCER
Module: Tobacco Effects and Neoplasia
SMOKING.
Smoking.
By: Keri Verdell Anna Henderson Lexy Tauber
LUNG DISEASES © 2016 Paul Billiet ODWS.
Fumo di sigaretta e tumori. Strategie di prevenzione
The Respiratory system
Prospective Studies Collaboration Lancet 2009; 373:
Tobacco (chapter 10.1).
Diseases & Death.
Respiratory System In Class Notes:.
Respiratory System In Class Notes:.
The Respiratory System
Recent health impact research in Denmark
Patterns of p53 mutations according to smoking habits in a) all lung cancers minus nonsmokers (n = 1,289), b) smokers with lung cancer (n = 419), c) nonsmokers.
Tobacco Review.
Short Term Effects of Tobacco
The Respiratory System
- - - TABLE 1 A cohort study Vitamin deficiency Depression +
Presentation transcript:

Paolo Vineis University of Torino and ISI Foundation EPIC: Molecular markers of carcinogenesis in a large prospective study

EPIC is a prospective study on more than 500,000 Europeans (aged 45-70) in 10 countries Two questionnaires (diet+other lifestyle factors) and blood samples in liquid nitrogen 24-hor recall from 10%

“GENAIR” Nested case-control study among the 500,000 EPIC volunteers: cancers of lung, bladder, larynx, pharynx, leukemias, COPD, emphysema Follow-up until 2002: 1104 cases and 2983 controls (MATCH 1:3) Non smokers+ex-smokers (since at least 10 yrs), matched by smoking habits, age, gender, time since blood drawing, country

CASES: BLADDER CANCER241 LEUKEMIA319 LUNG275 ORAL73 LARYNX AND PHARYNX 63 RESPIRATORY DEATHS133 EXPOSURE ASSESSMENT (HOEK) ALMOST COMPLETED DETAILS IN THIRD TECHNICAL REPORT (MAY 2003) IN

827 CASES AND 1562 CONTROLS (1:2 MATCH) HAVE BIOLOGICAL SAMPLES ANALYSES UNDER WAY, ALMOST COMPLETED FOR DNA ADDUCTS AND POLYMORPHISMS, N=1800 Only a subsample analyzed for more complex markers such as p53 mutations in plasma and for 4-ABP hemoglobin adducts (N=458)

Exposure assessment for air pollution (G Hoek, M Krzyzanowski, Bilthoven) Bulky (aromatic) DNA adducts in WBC (M Peluso, Genova) Hemoglobin adducts (4-ABP, benzopyrene) (L Airoldi, Milano) Cotinine and antioxidants in plasma (L Airoldi, Milano; E Riboli, Lyon)

DNA repair polymorphisms (G. Matullo, Torino; A. Dunning, Cambridge) Metabolic polymorphisms (C. Malaveille, Lyon; H Autrup, Copenhagen; S Garte, Milano) Mutations in p53 and ras in plasma DNA (P Hainaut, Lyon) Mathematical models (F Veglia, Torino)

Advantage of prospective study: markers are measured in blood drawn years before the onset of disease, i.e. the measurement is not influenced by the presence of disease (metabolic alterations) Blood is stored at - 196° C in liquid nitrogen

Exposure assessment for air pollution: contrasts populationPM10 (a) Italy (Florence, Varese, Torino)36,177>40 Several locations in France71,95122 Oxford56,45324 Cambridge28,90424 Bilthoven21,63536 Utrecht16,58436 Denmark (Copenhagen, Aarhus)55,25924 Umea24,590<10 (a) microg/m 3

Exposure Environment Environment Occupation Occupation Tobacco Tobacco Diet Diet Medicines Medicines Hormones Hormones Cosmetics, hair dyes etc. Cosmetics, hair dyes etc.Metabolism Gene expression Gene expression Enzyme activity Enzyme activity Gene polymorphism Gene polymorphism DNA damage Carcinogen - DNA adducts Carcinogen - DNA adducts DNA strand breaks DNA strand breaks Cancer cell Cancer risk Cancer risk Detoxification DNA repair Apoptosis Silent mutation

ADDUCTS PRELUDE TO MUTATIONS? DENISSENKO ET AL (1996) HAVE SHOWN THAT THERE WAS A STRONG SELECTIVE FORMATION OF ADDUCTS BY 7,8,9,10- tetrahydrobenzo(a)pyrene AT GUANINES IN CpG SEQUENCES OF CODONS 157, 248 AND 273 OF P53 GENE, THE MAJOR MUTATIONAL HOTSPOTS IN LUNG CANCER

ROLE OF POLYMORPHISMS FOR DNA REPAIR: XRCC1, XRCC3, XPD (RARE ALLELES) AND THEIR COMBINATION - MODULATION OF DNA ADDUCTS IN EPIC ITALY (Matullo et al, CEBP, 2003)

Some theoretical considerations: What is susceptibility on a population scale?

Burnet NG, Johansen J, Turesson I, Nyman J, Peacock JH. Describing patients’ normal tissue reactions concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Int. J. Cancer 1998; 79:

HYPOTHESES: 1. GENETIC SUSCEPTIBILITY HAS A CONTINUOUS DISTRIBUTION, WITH HIGLY PENETRANT GENES THAT CONFER EXCEPTIONALLY HIGH RISKS OF DISEASE, AND LOW-PENETRANT GENES THAT MODULATE THE RESPONSES 2. THE COMBINATION OF GENES IS MORE IMPORTANT THAN SINGLE GENES 3. LOW-PENETRANT GENES ARE MORE IMPORTANT AT LOW DOSES (I.E. A LOW DOSE IS SUFFICIENT TO INDUCE THE DISEASE IN SUSCEPTIBLE PERSONS)

SHAPE OF DOSE-RESPONSE RELATIONSHIPS IN PRESENCE OF MODULATION FROM POLIMORPHIC GENES: 1. EXAMPLE OF CYP1A1 MSPI (Vineis et al, Int. J Cancer 2003; 104: 650): the dose effect is greater in polymorphic individuals 2. EXAMPLE OF NAT2 (Vineis, Alavanja, Garte, Int J Cancer 2003 in press): the effect of polymorphism is greater at low doses

Genetic alterations in plasma DNA * Useful when tumours not available * Good concordance between tumour and plasma mutations * When does tumour DNA appear in the blood? * Can plasma DNA be used as a biomarker for genotoxic exposure?

DNA concentration sorted by EPIC number (origin) Oxford Cambridge Utrecht

Genetic alterations in GENAIR plasma DNA * TP53 mutations and CDKN2a hypermethylation * Mutations K-ras codon 12: Mutant Enriched PCR

Distribution of cases and controls according to p53 mutations (WT=wildtype). Controls All cancersOdds ratio (95% CI) Mutated ( ) WT p=0.02

Distribution of cases+controls according to p53 mutations (WT=wildtype) and presence or absence of P 32 - postlabelling DNA adducts. ADDUCTSOdds ratio yesno(95% CI) Mutated (0.6-35) WT

Distribution of 6 mutated incident cases according to time between p53 mutation and cancer onset (months) monthssmoking bladder1.8never bladder6.3former bladder32.2never leukemia8.6former lung18.1never lung19.1former

Distribution of cases+controls according to p53 mutations (WT=wildtype) and genotype for XRCC1 (polymorphism in codon 28152). AAAG GG Mutated431 WT OR p=0.006 Cases only Mutated311 WT OR10.31.l1.0 p=0.02

THE END